Scientists track patients for years after experimental cancer treatment
Disease control
Completed
This study monitored 20 patients who had previously received an experimental treatment called 177Lu-satoreotide tetraxetan for neuroendocrine tumors. Researchers tracked their long-term health to check for any delayed side effects or new cancers that might be related to the treat…
Phase: NA • Sponsor: Ariceum Therapeutics GmbH • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC